They stress that there is little evidence of benefit for healthy people and that the treatments can be very expensive
But when you look closer, the win is a lot less clear
Knowing the limitations helps you stay realistic and committed
A recent trial comparing tirzepatide to semaglutide showed a greater increase in weight loss after a year, with losses of 15.3% with tirzepatide compared with 8.3% for semaglutide
(GLP-1s are thought to curb cravings by targeting the brains reward pathway, which involves the release of dopamine.) So in these patients, too, weight loss is likely and they could also contend with the unwanted aesthetic effects of Ozempic
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease